Expansion platform type II: testing a treatment strategy.
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA. Electronic address: dcatenac@medicine.bsd.uchicago.edu.
Daniel V T
DV
Catenacci
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D025202:Molecular Diagnostic Techniques; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy*; D057285:Precision Medicine
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor